House probes DEA fentanyl walk tactic
Analysis based on 11 articles · First reported Aug 31, 2026 · Last updated Aug 31, 2026
The investigation could lead to stricter enforcement of fentanyl trafficking, potentially reducing the supply of illicit fentanyl and impacting the illegal drug market. It may also affect public perception of the DEA and the Justice Department, but direct financial market impact is limited.
The United States — United States House Committee on Oversight and Government Reform, led by Chairman James Comey, has launched an investigation into the United States — Drug Enforcement Administration's practice of allowing large fentanyl shipments to reach the streets in order to build bigger drug cases. Comer sent a letter to Attorney General Todd Blanche requesting records related to this strategy, which he says resulted in considerable harm and lives lost. The inquiry follows an AP investigation and a lawsuit by Mexico Attorney General Raúl Torrez against the United States — United States Department of Justice. The DEA's tactic, known as allowing drugs to 'walk,' was used in Mexico between 2023 and 2025, and continued into the Trump administration, culminating in the largest fentanyl bust in DEA history in May 2025. The Justice Department's internal watchdog has also announced a nationwide review of the practice.
Set up alerts, explore entity relationships, search across thousands of events, and build custom intelligence feeds.
Open Dashboard